318 related articles for article (PubMed ID: 26645190)
1. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
Ruperto N; Pistorio A; Oliveira S; Zulian F; Cuttica R; Ravelli A; Fischbach M; Magnusson B; Sterba G; Avcin T; Brochard K; Corona F; Dressler F; Gerloni V; Apaz MT; Bracaglia C; Cespedes-Cruz A; Cimaz R; Couillault G; Joos R; Quartier P; Russo R; Tardieu M; Wulffraat N; Bica B; Dolezalova P; Ferriani V; Flato B; Bernard-Medina AG; Herlin T; Trachana M; Meini A; Allain-Launay E; Pilkington C; Vargova V; Wouters C; Angioloni S; Martini A;
Lancet; 2016 Feb; 387(10019):671-678. PubMed ID: 26645190
[TBL] [Abstract][Full Text] [Related]
2. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
3. The PRINTO juvenile dermatomyositis trial.
Dale A; Milosevic I; Goldacre B;
Lancet; 2016 Jun; 387(10038):2600-2601. PubMed ID: 27353816
[No Abstract] [Full Text] [Related]
4. The PRINTO juvenile dermatomyositis trial - Authors' reply.
Ruperto N; Pistorio A; Ravelli A; Angioloni S; Martini A;
Lancet; 2016 Jun; 387(10038):2601. PubMed ID: 27353819
[No Abstract] [Full Text] [Related]
5. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
6. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Kasteler JS; Callen JP
J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
[TBL] [Abstract][Full Text] [Related]
7. Progress in the treatment of juvenile dermatomyositis.
Miossec P
Lancet; 2016 Feb; 387(10019):627-628. PubMed ID: 26645191
[No Abstract] [Full Text] [Related]
8. Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Beer TM; Hotte SJ; Saad F; Alekseev B; Matveev V; Fléchon A; Gravis G; Joly F; Chi KN; Malik Z; Blumenstein B; Stewart PS; Jacobs CA; Fizazi K
Lancet Oncol; 2017 Nov; 18(11):1532-1542. PubMed ID: 29033099
[TBL] [Abstract][Full Text] [Related]
9. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Mateos MV; Cavo M; Blade J; Dimopoulos MA; Suzuki K; Jakubowiak A; Knop S; Doyen C; Lucio P; Nagy Z; Pour L; Cook M; Grosicki S; Crepaldi A; Liberati AM; Campbell P; Shelekhova T; Yoon SS; Iosava G; Fujisaki T; Garg M; Krevvata M; Chen Y; Wang J; Kudva A; Ukropec J; Wroblewski S; Qi M; Kobos R; San-Miguel J
Lancet; 2020 Jan; 395(10218):132-141. PubMed ID: 31836199
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
Reiff A; Rawlings DJ; Shaham B; Franke E; Richardson L; Szer IS; Bernstein BH
J Rheumatol; 1997 Dec; 24(12):2436-43. PubMed ID: 9415655
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Mateos MV; Oriol A; Martínez-López J; Gutiérrez N; Teruel AI; de Paz R; García-Laraña J; Bengoechea E; Martín A; Mediavilla JD; Palomera L; de Arriba F; González Y; Hernández JM; Sureda A; Bello JL; Bargay J; Peñalver FJ; Ribera JM; Martín-Mateos ML; García-Sanz R; Cibeira MT; Ramos ML; Vidriales MB; Paiva B; Montalbán MA; Lahuerta JJ; Bladé J; Miguel JF
Lancet Oncol; 2010 Oct; 11(10):934-41. PubMed ID: 20739218
[TBL] [Abstract][Full Text] [Related]
13. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
[TBL] [Abstract][Full Text] [Related]
14. Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.
Ravelli A; Davì S; Bracciolini G; Pistorio A; Consolaro A; van Dijkhuizen EHP; Lattanzi B; Filocamo G; Verazza S; Gerloni V; Gattinara M; Pontikaki I; Insalaco A; De Benedetti F; Civino A; Presta G; Breda L; Marzetti V; Pastore S; Magni-Manzoni S; Maggio MC; Garofalo F; Rigante D; Gattorno M; Malattia C; Picco P; Viola S; Lanni S; Ruperto N; Martini A;
Lancet; 2017 Mar; 389(10072):909-916. PubMed ID: 28162781
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.
Hasija R; Pistorio A; Ravelli A; Demirkaya E; Khubchandani R; Guseinova D; Malattia C; Canhao H; Harel L; Foell D; Wouters C; De Cunto C; Huemer C; Kimura Y; Mangge H; Minetti C; Nordal EB; Philippet P; Garozzo R; Martini A; Ruperto N;
Arthritis Rheum; 2011 Oct; 63(10):3142-52. PubMed ID: 21647864
[TBL] [Abstract][Full Text] [Related]
16. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M; Parker C; Saad F; Miller K; Tombal B; Ng QS; Boegemann M; Matveev V; Piulats JM; Zucca LE; Karyakin O; Kimura G; Matsubara N; Nahas WC; Nolè F; Rosenbaum E; Heidenreich A; Kakehi Y; Zhang A; Krissel H; Teufel M; Shen J; Wagner V; Higano C
Lancet Oncol; 2019 Mar; 20(3):408-419. PubMed ID: 30738780
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R; Mysler E; Hall S; Kivitz AJ; Moots RJ; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS;
Lancet; 2017 Jul; 390(10093):457-468. PubMed ID: 28629665
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial.
Schmitt J; Schäkel K; Fölster-Holst R; Bauer A; Oertel R; Augustin M; Aberer W; Luger T; Meurer M
Br J Dermatol; 2010 Mar; 162(3):661-8. PubMed ID: 19863501
[TBL] [Abstract][Full Text] [Related]
19. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P; Maho-Vaillant M; Prost-Squarcioni C; Hebert V; Houivet E; Calbo S; Caillot F; Golinski ML; Labeille B; Picard-Dahan C; Paul C; Richard MA; Bouaziz JD; Duvert-Lehembre S; Bernard P; Caux F; Alexandre M; Ingen-Housz-Oro S; Vabres P; Delaporte E; Quereux G; Dupuy A; Debarbieux S; Avenel-Audran M; D'Incan M; Bedane C; Bénéton N; Jullien D; Dupin N; Misery L; Machet L; Beylot-Barry M; Dereure O; Sassolas B; Vermeulin T; Benichou J; Musette P;
Lancet; 2017 May; 389(10083):2031-2040. PubMed ID: 28342637
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
